News Article,Video
Maple Grove Medical Device Company Shares How They are Surviving During COVID-19
October 5, 2020
CCX Media visited Francis Medical on September 30, 2020, to interview President and CEO Mike Kujak, and get an inside look at how we’re thriving and moving forward during the COVID-19 pandemic, including a $4M investment from world-renown urology company, Coloplast. (2 1/2 min video)
Recent Posts
Press Release: Francis Medical Announces Completion of Enrollment in the VAPOR 2 Pivotal Study for Vanquish Prostate Cancer Treatment
February 25, 2025: Francis Medical completes enrollment in the company's VAPOR 2 Pivotal Study for Vanquish Prostate Cancer Treatment
Press Release: Francis Medical Announces Close of Record $80 Million Series C Equity Financing
January 8, 2025: Francis Medical raises record $80M in Series C to fund its VAPOR 2 study and U.S. launch of Vanquish, its proprietary prostate cancer treatment
CEO Mike Kujak Interviewed by Medtech Insight
In a revealing interview with Citeline Commercial's Medtech Insight, CEO Mike Kujak discusses how Francis Medical's Vanquish system is set to redefine prostate cancer treatment
Federal law (USA) restricts this device to sale by or on the order of a physician.
Refer to the device User Manual for a list of contraindications, warnings, and cautions.
Training: Do not operate the Vanquish System without completing Francis Medical-provided physician training. Untrained operation of the device may lead to improper use. Improper use can result in patient injury or equipment malfunction.